WHO Staging of HIV and AIDS.ppt

2,558 views 27 slides Oct 05, 2022
Slide 1
Slide 1 of 27
Slide 1
1
Slide 2
2
Slide 3
3
Slide 4
4
Slide 5
5
Slide 6
6
Slide 7
7
Slide 8
8
Slide 9
9
Slide 10
10
Slide 11
11
Slide 12
12
Slide 13
13
Slide 14
14
Slide 15
15
Slide 16
16
Slide 17
17
Slide 18
18
Slide 19
19
Slide 20
20
Slide 21
21
Slide 22
22
Slide 23
23
Slide 24
24
Slide 25
25
Slide 26
26
Slide 27
27

About This Presentation

health


Slide Content

Staging for HIV Infection
Wilson Okumu

2
Learning Outcomes
•Bytheendofthissession,youwillbe
expectedtobeableto:
•DiscussdiseasestagingandAIDS-defining
illnessbasedonWHOguidelines

3
What is Staging?
•Classificationoftheparticularstagereached
byaprogressivedisease

4
Why is Staging Important in HIV?
•TrackingandmonitoringtheHIV
epidemic
•Providingcliniciansandpatientswith
importantinformationaboutHIVdisease
stageandclinicalmanagement

5
What are the Staging Systems in use?
(1)U.S.CentersforDiseaseControland
Prevention(CDC)classificationsystem
(2)WorldHealthOrganization(WHO)
ClinicalStagingandDisease
ClassificationSystem

6
We will focus on WHO
clinical staging systems

7
Phases of HIV disease

8
Three Phases of HIV Infection
•CoursetakenbyHIVisunderstoodintermsof
interplaybetweenHIVandtheimmunesystem.

9
Phase I-The early, acute phase
•InitialresponseofanimmunocompetentadulttoHIV
infection
•Highlevelofvirusproductionandviraemia
widespreadviralseedingofthelymphoidtissuesand
1-2billionCD4+T-cellsdieeachday
•Clinicallycharacterizedbyinfectiousmononucleosis-
likefeaturesofsorethroat,myalgias,fever,weight
loss,andfatigue

10
Phase II-The middle, Chronic Phase
•Relativecontainmentofthevirusandclinicallatency
•Virusreplicationcontinuesforseveralyears,
•predominantlyinthelymphoidtissues
•Immunesystemlargelyintact
•Clinically,patientsareeitherasymptomaticor
developpersistentgeneralizedlymphadenopathy
(PGL).
•Manypatientshaveherpeszoster,oralthrush
21

11
Phase III-The Final Phase
•Breakdownofhostdefense
•CD4countusually<200cells/mm
3
•Suddenandrapidviraemia
•Clinically,thepatientpresentswithmarkedweight
loss,
•Chronicdiarrhoea,andfeverlastingmorethan1
month
•Opportunisticinfections(OI)occur
•TheclinicalpictureofAIDSwilldependonthetype
ofOI
22

12
Phase of HIV and AIDS
•Fourphasesemergefromdayzero
–Infection
–Windowperiod
–Seroconversion
–Asymptomaticperiod
–HIV/AIDS-relatedillness
•AIDS

13
CD4 Counts
•NumberofCD4cellsinbloodprovidesa
measureofimmunesystemdamage
•CD4countreflectsphaseofdisease
•CD4count:
–500–1200:Normal
–200–500:BeginningofHIVillness
–<200: AIDS

14
Window Period
•Timebetweeninfection&enough
antibodiesforapositiveHIVtest
•Duration:approximately3months
•Nosymptomsorsignsofillness
•HIVtestisnegative
•Virusismultiplyingrapidly-viralloadis
high
•Personisveryinfectious

15
Seroconversion
•PointatwhichHIVtestbecomespositive
•BodystartsmakingantibodiestoHIVafew
weeksafterinfection
•HIVtestbecomespositivewhenantibody
levelsarehighenoughtobemeasured
•Happensabout3monthsafterinfection
•Personmayhaveamildflu-likeillness,
lastingaweekortwothenthepersoniswell
again

16
Asymptomatic Periodic
•Timeperiodbetweenseroconversionand
onsetofHIV/AIDS-relatedillness
•Durationvariable:<1yearto>15years
•Most peopleremainhealthy
(asymptomatic)foraboutthreeyears
•Durationmaydependonsocio-economic
factors
•TheCD4countisabove500cells/ml

17
HIV-Related Illnesses & AIDS
•Timeperiodbetweenonsetofillness&
diagnosisofAIDS
•Durationisvariable:averageabout5
years
•Illnessesinitiallymild,withgradual
increaseinfrequencyandseverity
•CD4countisbetween500&200cells/ml

18
AIDS
•FinalphaseofHIV/AIDS
•Duration:withoutantiretroviraldrugs,less
than2yearswithandwithantiretrovirals,
manymanyyears
•CD4countisbelow200cells/ml
•Viralloadsarehigh&thepersonisvery
infectious
•HIVtestmaybecomenegative

19
WHO Clinical Staging of
HIV/AIDS

20
WHO Clinical Staging in Adults
AdultswithHIVinfectionareclassifiedinto4
clinicalstagesdependingonthepresenceof
HIV-relatedconditions

21
WHO Clinical Staging Criteria?
Classification WHO clinical stage
Asymptomatic 1
Mild 2
Advanced 3
Severe 4

WHO Clinical Stage 1-Primary HIV
Infection
•Asymptomatic
•PersistentGeneralized
Lymphadenopathy(PGL)
•Performance scale 1: asymptomatic,
normal activity

WHO Clinical Stage II-Asymptomatic
•Weightloss,<10%ofbodyweight
•Minormucocutaneousmanifestations(seborrheic
dermatitis,prurigo,
•Fungalnailinfections,recurrentoralulcerations,
angularcheilitis
•Herpeszosterwithinthelastfiveyears
•Recurrentupperrespiratorytractinfections
•And/orperformancescale2:symptomatic,normal
activity.

WHO Clinical Stage III-
Asymptomatic
24

WHO Clinical Stage IV-(HIV to AIDS)
•HIVwastingsyndrome,asdefinedbythe
CentersforDiseaseControlandPrevention
•Pneumocystiscariniipneumonia
•Toxoplasmosisofthebrain
•Cryptosporidiosiswithdiarrhoea>1month
•Cryptococcosis,extrapulmonary
•Cytomegalovirusdiseaseofanorganotherthan
liver,spleenorlymphnodes
•Herpessimplexvirusinfection,mucocutaneous
>1month,orvisceralanyduration
•Progressivemultifocalleukoencephalopathy

26
WHOClinicalStageIV-(HIVtoAIDS)
•Any disseminated endemic mycosis
(i.e.histoplasmosis,coccidioidomycosis)
•Candidiasisoftheoesophagus,trachea,bronchior
lungs
•Atypicalmycobacteriosis,disseminated
•Non-typhoidSalmonellasepticaemia
•Extrapulmonarytuberculosis
•Lymphoma
•Kaposi’ssarcoma
•HIVencephalopathy,asdefinedbytheCentersfor
DiseaseControlandPrevention.
•And/orperformancescale4:bedridden>50%ofthe
dayduringthelastmonth
32

27
ReferencesCited
•WHOCaseDefinitionsofHIVforSurveillanceand
RevisedClinicalStagingandImmunological
ClassificationofHIV-RelatedDiseaseinAdultsand
Children;2007.
•1993revisedclassificationsystemforHIVinfectionand
expandedsurveillancecasedefinitionforAIDSamong
adolescentsandadults.MMWRRecommRep.1992Dec
18;41(RR-17):1-19.
•Guidelinesfornationalhumanimmunodeficiencyvirus
casesurveillance,includingmonitoringforhuman
immunodeficiencyvirusinfectionandacquired
immunodeficiencysyndrome.MMWR RecommRep.
1999Dec10;48(RR-13):1-27,29-31.
Tags